William F Regine MD

Radiation Oncology•Baltimore, MD

Professor of Radiation Oncology, University MD School of Medicine

Join to View Full Profile

22 S Greene StGudelsky BasementBaltimore, MD 21201
Phone+1 410-328-3037
Fax+1 410-328-3040

Education & Training

Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Radiation Oncology, 1988 - 1992
St Joseph's HealthInternship, Transitional Year, 1987 - 1988
SUNY Upstate Medical UniversityClass of 1987

Certifications & Licensure

CA State Medical License 2006 - Present
MD State Medical License 2002 - 2025
FL State Medical License 2014 - 2016
KY State Medical License 1994 - 2003
TN State Medical License 1992 - 1995
PA State Medical License 1989 - 1994
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2009-2014
America's Top Doctors for Cancer Castle Connolly, 2005-2013
Top Doctors:Baltimore Area Castle Connolly, 2012
Top Doctors:Washington-Baltimore Castle Connolly, 2012
Super Doctor SuperDoctors.com
Top MD Consumers Checkbook
Join now to see all

Clinical Trials

Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas Start of enrollment: 1998 Jul 01
Completed
Phase 3
Evaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain Metastases Start of enrollment: 2000 Nov 01
Completed
Not Applicable
Capecitabine, Bevacizumab, and Radiation Therapy Followed By Gemcitabine and Bevacizumab in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery Start of enrollment: 2005 Jan 01
Completed
Phase 2
Low Dose Upper Abdominal Radiation Therapy (LD-UART) + Gemcitabine in Patients With Advanced, Unresectable Pancreatic Cancer (PC) Start of enrollment: 2003 Oct 01
Completed
Phase 1, Phase 2
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery Start of enrollment: 2010 Apr 05
ACTIVE_NOT_RECRUITING
PHASE3
Borderline Pancreas Study: FOLFIRINOX +SBRT Start of enrollment: 2014 Mar 01
Completed
Early Phase 1
Join now to see all

Publications & Presentations

PubMed

Forward momentum: progressive change through diversity equity and inclusion initiatives in academic health care.
Chaitanya Kalavagunta, Bansi Savla, Jessica White, Dominic Bulkley, Anna Dunlap
JNCI Cancer Spectrum. 2025-03-03
Clinical Implementation and Dosimetric Evaluation of a Robust Proton Lattice Planning Strategy Using Primary and Robust Complementary Beams.
Sina Mossahebi, Jason K Molitoris, Yannick Poirier, Jenna Jatczak, Baoshe Zhang
International Journal of Radiation Oncology, Biology, Physics. 2024-11-15
Results of an Integrated Phase I/II Prospective Clinical Trial (NEXIS) for Neoadjuvant Anti-PD-L1 (Durvalumab) and Anti-CTLA-4 (Tremelimumab) With Radiation for High-R...
Vincent Y Ng, Mario N Sahlani, Jessa D Fogel, Anthony K Chiu, Michael E Kallen
Cureus. 2024-10-01

Press Mentions

Innovative CT Scan Technique Could Improve Prognosis and Treatments for Head and Neck Cancers, New Research SuggestsFebruary 26th, 2025
New CT Scan Technique Holds Promise for Enhancing Prognosis and Treatment of Head and Neck Cancers, Research IndicatesFebruary 26th, 2025
Leading Healthcare Executive Rachel Hoover, MS, MBA, Named Executive Vice President at UM Faculty Physicians, Inc.May 15th, 2023
Join now to see all